RLMD’s latest rating updates from top analysts.

Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Jan 31 ’24. In the deal valued at $4.00 per share,27,460 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 244,024 shares worth roughly $1.35 million. Then, Ence Chuck bought […]

Relmada Therapeutics Inc (RLMD) Becoming More Attractive for Investors

In a filing, Relmada Therapeutics Inc revealed its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Jan 31. In the deal valued at $4.00 per share,27,460 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 244,024 shares worth roughly $1.66 million. Then, Ence Chuck bought 13,670 […]

A Guide To The Risks Of Investing In Relmada Therapeutics Inc (RLMD)

Relmada Therapeutics Inc’s recent filing unveils that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Jan 31. In the deal valued at $4.00 per share,27,460 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 244,024 shares worth roughly $1.36 million. Then, Ence Chuck bought 13,670 […]